Product
DRC
1 clinical trial
1 indication
Indication
Waldenstrom MacroglobulinemiaClinical trial
Efficacy of Venetoclax in Combination With Rituximab in Waldenström's MacroglobulinemiaStatus: Not yet recruiting, Estimated PCD: 2027-10-01
1 clinical trial
1 indication